BioNTech Halts Colorectal Cancer Trial Amid Broader German Corporate Developments

German biotech leader BioNTech suspends clinical testing for a new intestinal cancer treatment, while parallel corporate updates track Merz banking negotiations, retail insolvencies, and improving sentiment in the chemical sector.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

fazGerman19h ago

Business-Ticker: Biontech stoppt klinische Studie zu Darmkrebs-Therapie

Merz plant zunächst keine Gespräche mit Unicredit +++ Was passiert mit den Filialen der insolventen Baumarktkette Hellweg? +++ Chemieindustrie bewertet Geschäftslage erstmals seit vier Jahren positiv +++ Neuigkeiten im Unternehmen-Liveblog.

Read full article →

PERSPECTA

PERSPECTA

BioNTech Halts Colorectal Cancer Trial Amid Broader German Corporate Developments

Sources

Business-Ticker: Biontech stoppt klinische Studie zu Darmkrebs-Therapie

Related Stories

College Dropout Turns Full-Time Pokémon Card Reseller With $7.8M in Sales

Fed Chair Warsh Warns of Potential Rate Hikes Amid Stubborn Inflation

Temasek Backs Singapore Airlines’ Strategic Investment in Air India

Meta Agrees to $18 Billion Settlement Over Teen Safety Lawsuit

PERSPECTA